openPR Logo
Press release

Synergy's (NASDAQ: SNYR) "FOCUSfactor" Massive 50,000 Store Expansion Including Walmart (NYSE: WMT) Canada - Alongside MOGO, ELWS, DAIC - Stocks Under $5 to Watch

07-02-2025 11:08 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Synergy's (NASDAQ: SNYR) "FOCUSfactor" Massive 50,000 Store

Synergy CHC Corp. (NASDAQ: SNYR) has surged over 74% in the last 30 days, fueled by the execution of a sweeping retail expansion strategy for its flagship FOCUSfactor Registered brand, now available in both supplement and functional beverage form. The brand's rollout to over 50,000 locations-via Core-Mark, Walmart Canada, Metro Ontario, and Downey Wholesale-marks a major milestone, unlocking national reach across mass retail, grocery, convenience, and independent channels.

Walmart Canada will launch FOCUSfactor supplements nationwide in Q4 2025, further extending Synergy's 18-year partnership with Walmart (NYSE: WMT) in the U.S. Additionally, Synergy's flagship FOCUSfactor brain health supplement already has established distribution in the U.S. through Costco (NASDAQ: COST), Walmart (NYSE: WMT), Amazon (NASDAQ: AMZN), CVS (NYSE: CVS), Walgreens (NASDAQ: WBA) among others -with continued growth expected.

With nine consecutive profitable quarters, Synergy is poised to continue its momentum as demand grows for clean-label cognitive and energy-boosting products. The recent addition of beverage industry veteran Damian Marano-a former executive at The Coca-Cola Company (NYSE: KO)-is expected to accelerate global rollout opportunities, particularly in the better-for-you drink segment, which could significantly boost the company's overall revenues.

In addition to SNYR, stocks under $5 gaining attention include:

*
Mogo Inc. (NASDAQ: MOGO) - A digital finance and crypto platform riding a wave of cost efficiencies and increased transaction volume in Canada.

*
Earlyworks Co., Ltd. (NASDAQ: ELWS) - A Japanese blockchain innovator rapidly scaling its Web3 enterprise solutions.

*
CID HoldCo Inc. (NASDAQ: DAIC) - A recent IPO with growing momentum in the U.S. public markets, gaining traction with investors eyeing smallcap opportunities.

*
Power Metallic Mines Inc. (TSXV: PNPN) (OTCQB: PNPNF) - A Canadian junior mining company exploring nickel and copper assets, gaining investor interest amid rising criticalminerals demand.

*
Peraso Inc. (NASDAQ: PRSO) - A wireless semiconductor innovator focused on highthroughput 5G/6G connectivity, gaining attention for its intellectual property portfolio and commercial partnership pipeline.

With Synergy's expansive footprint, Mogo Inc. (NASDAQ: MOGO) 's fintech surge, Earlyworks Co., Ltd. (NASDAQ: ELWS) 's blockchain advancement, CID HoldCo Inc. (NASDAQ: DAIC)'s postIPO visibility, Power Metallic Mines Inc. (TSXV: PNPN)(OTCQB: PNPNF)'s criticalminerals upside, and Peraso Inc. (NASDAQ: PRSO)'s tech momentum, these under$5 stocks are rapidly emerging as key Q3 2025 opportunities.

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=synergys-nasdaq-snyr-focusfactor-massive-50000-store-expansion-including-walmart-nyse-wmt-canada-alongside-mogo-elws-daic-stocks-under-5-to-watch]
Country: United States
Website: http://www.thestreetreports.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Synergy's (NASDAQ: SNYR) "FOCUSfactor" Massive 50,000 Store Expansion Including Walmart (NYSE: WMT) Canada - Alongside MOGO, ELWS, DAIC - Stocks Under $5 to Watch here

News-ID: 4090288 • Views:

More Releases from ABNewswire

Most Personality Tests Were Built for Extroverts. Introvert Strength Quizzes Weren't.
Most Personality Tests Were Built for Extroverts. Introvert Strength Quizzes Wer …
A new platform challenges how quiet thinkers have been measured and misunderstood for decades. In a world that rewards speed, visibility, and constant expression, introverts have quietly adapted. They've learned to participate without dominating. To contribute without a spotlight. To think before speaking. But what if the very tools used to "understand" personality were never designed to measure introverted strength in the first place? Introvert Strength Quizzes launches with a bold premise: Introverts have
Biliary Tract Cancers Clinical Trial Pipeline Gains Momentum: 80+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
Biliary Tract Cancers Clinical Trial Pipeline Gains Momentum: 80+ Companies Lead …
DelveInsight's "Bladder Cancer Pipeline Insight 2026" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the Bladder cancer pipeline landscape. It covers the Bladder Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bladder Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our latest breakthroughs in
B-Cell Non-Hodgkin Lymphoma Clinical Trial Pipeline Gains Momentum: 75+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
B-Cell Non-Hodgkin Lymphoma Clinical Trial Pipeline Gains Momentum: 75+ Companie …
DelveInsight's "B-Cell Non-Hodgkin Lymphoma Pipeline Insight 2026" report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in B-Cell Non-Hodgkin Lymphoma pipeline landscape. It covers the B-Cell Non-Hodgkin Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the B-Cell Non-Hodgkin Lymphoma therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive B-cell non-Hodgkin Lymphoma pipeline products in this
Atopic Dermatitis Clinical Trial Pipeline Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
Atopic Dermatitis Clinical Trial Pipeline Gains Momentum: 100+ Companies Lead th …
DelveInsight's "Atopic Dermatitis Pipeline Insight 2026" report provides comprehensive insights about 100+ companies and 120+ pipeline drugs in the Atopic Dermatitis pipeline landscape. It covers the Atopic Dermatitis Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Atopic Dermatitis Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Curious about the latest updates

All 5 Releases


More Releases for NASDAQ:

Blasting Off with Space Sector Companies Including: Ascent Solar Technologies: N …
With the Artemis II Manned Moon Mission Set to Launch Could $ASTI be on the Same Rocket Ride Trajectory as $ASTS and $LUNR? Image: https://www.globalnewslines.com/uploads/2026/02/13b5a8ac7a0c22438ac498119e1b3551.jpg $ASTI is Positioned to Serve the $1 Trillion Global Space Economy Projected by 2040 . Ascent Solar Technologies, Inc. (NASDAQ: ASTI) is backed by 40 years of R&D, 15 years of manufacturing experience, numerous awards, and a comprehensive IP and patent portfolio. ASTI is a leading provider of
Peraso (NASDAQ: PRSO) Pushes Back on Mobix Labs (NASDAQ: MOBX) Takeover Bid, Val …
Peraso Inc. (NASDAQ: PRSO), a leading innovator in mmWave wireless solutions, has officially acknowledged receipt of an unsolicited, non-binding acquisition proposal from Mobix Labs, Inc. (NASDAQ: MOBX). The offer proposes a stock-for-stock exchange that values Peraso at approximately $1.20 per share, representing a 20% premium over its 30-day average closing price. However, Peraso is contesting several key points made in Mobix's June 26 press release. Financials Mischaracterized, Says Peraso Peraso rebuffed Mobix's
ZenaTech's (Nasdaq: ZENA) Nasdaq Listing: A Launchpad for Growth and Innovation
On October 1, ZenaTech (Nasdaq: ZENA) made its debut on the Nasdaq, a pivotal milestone for the company specializing in AI-driven drone solutions and enterprise SaaS (software-as-a-service) applications. As businesses increasingly seek innovative ways to streamline operations and boost productivity, ZenaTech stands ready to meet these demands with its advanced AI drone solutions and comprehensive software applications. Under the leadership of CEO Dr. Shaun Passley, ZenaTech aims to leverage its
Investors Alert: EMCORE (NASDAQ: EMKR), AGBA Group (NASDAQ: AGBA), Peraso Inc. ( …
EMCORE Corporation (NASDAQ: EMKR) saw its shares soar today following a major announcement from Mobix Labs (NASDAQ: MOBX). Mobix Labs, a leader in advanced wireless solutions for military and defense, has submitted a proposal to acquire all outstanding shares of EMCORE for $3.80 per share in cash, positioning itself as a key player in the aerospace and defense sectors. This move could provide immediate value to shareholders, making it an
Market Movers to Watch: Black Diamond (Nasdaq: BDTX), Peraso Inc. (NASDAQ: PRSO) …
Pre-market trading is heating up as Black Diamond Therapeutics, Inc. (Nasdaq: BDTX) surges on positive Phase 2 data for its cancer treatment BDTX-1535. Peraso Inc. (NASDAQ: PRSO) continues its expansion into the Asian markets and a major military contract. Kaival Brands (NASDAQ: KAVL) saw its stock surge in early trading today on merger announcement. Other stocks to watch include Banzai International Inc. (NASDAQ: BNZI), which saw a 97.51% rally after
Lawsuit filed for Investors who lost money with Alphabet Inc. (NASDAQ: GOOG, NAS …
An investor, who purchased shares of Alphabet Inc. (NASDAQ: GOOG, NASDAQ: GOOGL), filed a lawsuit over alleged violations of Federal Securities Laws by Alphabet Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Alphabet Inc. (NASDAQ: GOOG, NASDAQ: GOOGL), have certain options and for certain investors are short and strict deadlines running. Deadline: May 15, 2023. NASDAQ: GOOG, NASDAQ: GOOGL investors should contact the Shareholders